MBRX ▲ +2.3% - Moleculin Biotech, Inc. $MBRX - Moleculin Announces Acceptance of Annamycin Data for Presentation at the 2026 American Society of Hematology (ASH) Annual Meeting 04-NOV-2026 11:00 AM ET